Cleavage of Tropomodulin-3 by Asparagine Endopeptidase Promotes Cancer Malignancy by Actin Remodeling and SND1/RhoA Signaling

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2022 Jun 28

PMID 35765111

Authors

Binghong Chen

Mengying Wang

Junjun Qiu

Keman Liao

Wenrui Zhang

Qi Lv

Chunhui Ma

Zhongrun Qian

Zhonggang Shi

Rong Liang

Yan Lin

Jiazhou Ye

Yongming Qiu

Yingying Lin

Affiliations

Soon will be listed here.

Abstract

Background: Abnormal proliferation and migration of cells are hallmarks of cancer initiation and malignancy. Asparagine endopeptidase (AEP) has specific substrate cleavage ability and plays a pro-cancer role in a variety of cancers. However, the underlying mechanism of AEP in cancer proliferation and migration still remains unclear.

Methods: Co-immunoprecipitation and following mass spectrometry were used to identify the substrate of AEP. Western blotting was applied to measure the expression of proteins. Single cell/nuclear-sequences were done to detect the heterogeneous expression of Tmod3 in tumor tissues. CCK-8 assay, flow cytometry assays, colony formation assay, Transwell assay and scratch wound-healing assay were performed as cellular functional experiments. Mouse intracranial xenograft tumors were studied in in vivo experiments.

Results: Here we showed that AEP cleaved a ubiquitous cytoskeleton regulatory protein, tropomodulin-3 (Tmod3) at asparagine 157 (N157) and produced two functional truncations (tTmod3-N and tTmod3-C). Truncated Tmod3 was detected in diverse tumors and was found to be associated with poor prognosis of high-grade glioma. Functional studies showed that tTmod3-N and tTmod3-C enhanced cancer cell migration and proliferation, respectively. Animal models further revealed the tumor-promoting effects of AEP truncated Tmod3 in vivo. Mechanistically, tTmod3-N was enriched in the cell cortex and competitively inhibited the pointed-end capping effect of wild-type Tmod3 on filamentous actin (F-actin), leading to actin remodeling. tTmod3-C translocated to the nucleus, where it interacted with Staphylococcal Nuclease And Tudor Domain Containing 1 (SND1), facilitating the transcription of Ras Homolog Family Member A/Cyclin Dependent Kinases (RhoA/CDKs).

Conclusion: The newly identified AEP-Tmod3 protease signaling axis is a novel "dual-regulation" mechanism of tumor cell proliferation and migration. Our work provides new clues to the underlying mechanisms of cancer proliferation and invasive progression and evidence for targeting AEP or Tmod3 for therapy.

Citing Articles

Intranasal delivery of AEP inhibitor-loaded neuron-targeted liposome ameliorates radiation-induced brain injury.

Liao K, Gao Y, Cheng M, Zhang Y, Zhao J, Zhou L Mater Today Bio. 2025; 31:101568.

PMID: 40026629 PMC: 11872414. DOI: 10.1016/j.mtbio.2025.101568.

Radiotherapy resistance driven by Asparagine endopeptidase through ATR pathway modulation in breast cancer.

Morillo-Huesca M, G Lopez-Cepero I, Conesa-Bakkali R, Tome M, Watts C, Huertas P J Exp Clin Cancer Res. 2025; 44(1):74.

PMID: 40012043 PMC: 11866873. DOI: 10.1186/s13046-025-03334-6.

Non-Canonical, Extralysosomal Activities of Lysosomal Peptidases in Physiological and Pathological Conditions: New Clinical Opportunities for Cancer Therapy.

Conesa-Bakkali R, Morillo-Huesca M, Martinez-Fabregas J Cells. 2025; 14(2).

PMID: 39851495 PMC: 11763575. DOI: 10.3390/cells14020068.

Proteomic Profiling of Pre- and Post-Surgery Saliva of Glioblastoma Patients: A Pilot Investigation.

Muntiu A, Moresi F, Vincenzoni F, Rossetti D, Iavarone F, Messana I Int J Mol Sci. 2024; 25(23).

PMID: 39684695 PMC: 11641718. DOI: 10.3390/ijms252312984.

Asparagine endopeptidase deficiency mitigates radiation-induced brain injury by suppressing microglia-mediated neuronal senescence.

Qiu O, Zhao J, Shi Z, Li H, Wang S, Liao K iScience. 2024; 27(5):109698.

PMID: 38655198 PMC: 11035374. DOI: 10.1016/j.isci.2024.109698.

References

Siegel R, Miller K, Fuchs H, Jemal A . Cancer Statistics, 2021. CA Cancer J Clin. 2021; 71(1):7-33. DOI: 10.3322/caac.21654. View

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

Ostrom Q, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan J . CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. Neuro Oncol. 2018; 20(suppl_4):iv1-iv86. PMC: 6129949. DOI: 10.1093/neuonc/noy131. View

Wen P, Weller M, Quant Lee E, Alexander B, Barnholtz-Sloan J, Barthel F . Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol. 2020; 22(8):1073-1113. PMC: 7594557. DOI: 10.1093/neuonc/noaa106. View

Tan A, Ashley D, Lopez G, Malinzak M, Friedman H, Khasraw M . Management of glioblastoma: State of the art and future directions. CA Cancer J Clin. 2020; 70(4):299-312. DOI: 10.3322/caac.21613. View

Chantaravisoot N, Wongkongkathep P, Loo J, Mischel P, Tamanoi F . Significance of filamin A in mTORC2 function in glioblastoma. Mol Cancer. 2015; 14:127. PMC: 4489161. DOI: 10.1186/s12943-015-0396-z. View

Ziemann A, Hess S, Bhuwania R, Linder S, Kloppenburg P, Noegel A . CRN2 enhances the invasiveness of glioblastoma cells. Neuro Oncol. 2013; 15(5):548-61. PMC: 3635520. DOI: 10.1093/neuonc/nos388. View

Mikheeva S, Mikheev A, Petit A, Beyer R, Oxford R, Khorasani L . TWIST1 promotes invasion through mesenchymal change in human glioblastoma. Mol Cancer. 2010; 9:194. PMC: 2920263. DOI: 10.1186/1476-4598-9-194. View

Hall A . The cytoskeleton and cancer. Cancer Metastasis Rev. 2009; 28(1-2):5-14. DOI: 10.1007/s10555-008-9166-3. View

10.

Xie Z, Janczyk P, Zhang Y, Liu A, Shi X, Singh S . A cytoskeleton regulator AVIL drives tumorigenesis in glioblastoma. Nat Commun. 2020; 11(1):3457. PMC: 7351761. DOI: 10.1038/s41467-020-17279-1. View

11.

Brand F, Forster A, Christians A, Bucher M, Thome C, Raab M . FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas. Acta Neuropathol. 2019; 139(1):175-192. DOI: 10.1007/s00401-019-02067-z. View

12.

Sato M, Kakui Y, Toya M . Tell the Difference Between Mitosis and Meiosis: Interplay Between Chromosomes, Cytoskeleton, and Cell Cycle Regulation. Front Cell Dev Biol. 2021; 9:660322. PMC: 8060462. DOI: 10.3389/fcell.2021.660322. View

13.

Gray K, Kostyukova A, Fath T . Actin regulation by tropomodulin and tropomyosin in neuronal morphogenesis and function. Mol Cell Neurosci. 2017; 84:48-57. PMC: 5648638. DOI: 10.1016/j.mcn.2017.04.002. View

14.

Gray K, Stefen H, Ly T, Keller C, Colpan M, Wayman G . Tropomodulin's Actin-Binding Abilities Are Required to Modulate Dendrite Development. Front Mol Neurosci. 2018; 11:357. PMC: 6190845. DOI: 10.3389/fnmol.2018.00357. View

15.

Parreno J, Fowler V . Multifunctional roles of tropomodulin-3 in regulating actin dynamics. Biophys Rev. 2018; 10(6):1605-1615. PMC: 6297098. DOI: 10.1007/s12551-018-0481-9. View

16.

Colpan M, Moroz N, Kostyukova A . Tropomodulins and tropomyosins: working as a team. J Muscle Res Cell Motil. 2013; 34(3-4):247-60. PMC: 4774520. DOI: 10.1007/s10974-013-9349-6. View

17.

Fowler V, Dominguez R . Tropomodulins and Leiomodins: Actin Pointed End Caps and Nucleators in Muscles. Biophys J. 2017; 112(9):1742-1760. PMC: 5425412. DOI: 10.1016/j.bpj.2017.03.034. View

18.

Rao J, Madasu Y, Dominguez R . Mechanism of actin filament pointed-end capping by tropomodulin. Science. 2014; 345(6195):463-7. PMC: 4367809. DOI: 10.1126/science.1256159. View

19.

Naumanen P, Lappalainen P, Hotulainen P . Mechanisms of actin stress fibre assembly. J Microsc. 2008; 231(3):446-54. DOI: 10.1111/j.1365-2818.2008.02057.x. View

20.

Carlier M, Shekhar S . Global treadmilling coordinates actin turnover and controls the size of actin networks. Nat Rev Mol Cell Biol. 2017; 18(6):389-401. DOI: 10.1038/nrm.2016.172. View